Literature DB >> 15859671

Performance status assessment in home hospice patients using a modified form of the Karnofsky Performance Status Scale.

S Nikoletti1, D Porock, L J Kristjanson, K Medigovich, P Pedler, M Smith.   

Abstract

The Karnofsky Performance Status (KPS) scale is considered to be the gold standard for quantifying the physical functioning of patients with cancer. However, problems have been identified with the scoring system when the scale is used in the home hospice setting. The goal of this study was to compare assessments of performance status using two instruments, the KPS and a modified version, the Thorne-KPS (TKPS). The TKPS avoids reference to location of care and has new descriptors for assessing the frequency of professional visits and the proportion of time spent in bed. Comparisons were made on a sample of 78 home-hospice patients in Perth, Western Australia. The median score for both scales was 60. The scales agreed in 56% of ratings overall but after correcting for chance, agreement was reduced to 47%. However, 91% of the 34 discrepancies occurred within one or two levels of the 11-point scale. TKPS scores were consistently lower than KPS scores and were spread over a wider range of the scale. The strongest agreement occurred at the higher levels of performance and the weakest agreement was within the middle levels of the scales. Further studies are required to determine which of the two scales more accurately reflects performance status and survival time. However, the results to date suggest that the TKPS may be a more objective and sensitive measure of functional performance in home hospice patients.

Entities:  

Year:  2000        PMID: 15859671     DOI: 10.1089/jpm.2000.3.301

Source DB:  PubMed          Journal:  J Palliat Med        ISSN: 1557-7740            Impact factor:   2.947


  8 in total

1.  Development of a computer-administered mobility questionnaire.

Authors:  Jorunn L Helbostad; Line M Oldervoll; Peter M Fayers; Marit S Jordhøy; Kenneth C H Fearon; Florian Strasser; Stein Kaasa
Journal:  Support Care Cancer       Date:  2010-03-26       Impact factor: 3.603

2.  Predictors of survival in surgically treated patients of spinal metastasis.

Authors:  Pravin Padalkar; Benjamin Tow
Journal:  Indian J Orthop       Date:  2011-07       Impact factor: 1.251

3.  The Australia-modified Karnofsky Performance Status (AKPS) scale: a revised scale for contemporary palliative care clinical practice [ISRCTN81117481].

Authors:  Amy P Abernethy; Tania Shelby-James; Belinda S Fazekas; David Woods; David C Currow
Journal:  BMC Palliat Care       Date:  2005-11-12       Impact factor: 3.234

4.  Treatment efficacy of (153)Sm-EDTMP for painful bone metastasis.

Authors:  Narjess Ayati; Kamran Aryana; Amir Jalilian; Toktam Hoseinnejad; Ali Bahrami Samani; Zahra Ayati; Farzane Shariati; S Rasoul Zakavi
Journal:  Asia Ocean J Nucl Med Biol       Date:  2013

5.  The feasibility of a single-blinded fast-track pragmatic randomised controlled trial of a complex intervention for breathlessness in advanced disease.

Authors:  Morag C Farquhar; Irene J Higginson; Petrea Fagan; Sara Booth
Journal:  BMC Palliat Care       Date:  2009-07-07       Impact factor: 3.234

6.  Appraisal of the Karnofsky Performance Status and proposal of a simple algorithmic system for its evaluation.

Authors:  Dominik Péus; Nicolas Newcomb; Silvia Hofer
Journal:  BMC Med Inform Decis Mak       Date:  2013-07-19       Impact factor: 2.796

Review 7.  Functional Decline in the Cancer Patient: A Review.

Authors:  Jaidyn Muhandiramge; Suzanne G Orchard; Erica T Warner; Gijsberta J van Londen; John R Zalcberg
Journal:  Cancers (Basel)       Date:  2022-03-08       Impact factor: 6.639

8.  Palliative care needs in patients hospitalized with heart failure (PCHF) study: rationale and design.

Authors:  Ross T Campbell; Colette E Jackson; Ann Wright; Roy S Gardner; Ian Ford; Patricia M Davidson; Martin A Denvir; Karen J Hogg; Miriam J Johnson; Mark C Petrie; John J V McMurray
Journal:  ESC Heart Fail       Date:  2015-03-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.